---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-24-006646"
form_type: "8-K"
ticker: "ADCT"
cik: "0001771910"
company_name: "ADC Therapeutics SA"
filed_at: "2024-05-14T23:59:59+00:00"
generated_at: "2026-06-02T01:03:18.010874+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# ADC Therapeutics posts corporate presentation; no material new disclosures identified

## Summary
- Presentation dated May 14, 2024 made available for industry conferences and investor meetings.
- No specific financial or operational metrics disclosed in the 8-K or exhibit summary.
- Presentation contains forward-looking statements; limited detail on pipeline or guidance.

## SEC filing metadata
- accession: 0000950103-24-006646
- form_type: 8-K
- ticker: ADCT
- cik: 0001771910
- company_name: ADC Therapeutics SA
- filed_at: 2024-05-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1771910/000095010324006646/0000950103-24-006646-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1771910/000095010324006646/dp211180_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-24-006646
- JSON: https://secwatch.observer/filing/0000950103-24-006646.json
- Plain text: https://secwatch.observer/filing/0000950103-24-006646.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.